Kinarus Therapeutics Holding AG

Market Cap: N/A
Industry: Pharmaceuticals & Biotechnology
ISIN: CH0009115129

CHF

21.40

-0.6 (-2.73%)

Mar 27

SWX

View all stocks in this country

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Compare Kinarus Therapeutics Holding AG with Similar Stocks

ObsEva SA Addex Therapeutics Ltd.Spexis Ltd.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

CHF 59 Million ()

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.07

Return on Equity

-31.22%

Price to Book

1.30

Revenue and Profits:

Net Sales:

(Quarterly Results - )

Net Profit:

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

85.28%

6 Months

47.59%

1 Year

86.09%

2 Years

509423.81%

3 Years

201786.79%

4 Years

30914.49%

5 Years

26650.0%

Kinarus Therapeutics Holding AG for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-16.77%

EBIT Growth (5y)

-210.80%

EBIT to Interest (avg)

-2.19

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.07

Sales to Capital Employed (avg)

7.12

Tax Ratio

6.30%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

12.71%

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.30

EV to EBIT

-3.62

EV to EBITDA

-15.00

EV to Capital Employed

1.32

EV to Sales

5.28

PEG Ratio

Dividend Yield

ROCE (Latest)

-36.59%

ROE (Latest)

-31.22%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bearish

Bollinger Bands

Mildly Bullish

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Mildly Bearish

Dow Theory

Mildly Bullish

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Kinarus Therapeutics Holding AG"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "alert": "No Annual Results declared by Kinarus Therapeutics Holding AG"
  }
]

Company CV

About Kinarus Therapeutics Holding AG

Kinarus Therapeutics Holding AG

Pharmaceuticals & Biotechnology

Perfect Holding SA is a Switzerland-based company that focuses on the acquisition and management of investments in companies, which are active in the aircraft management and related services sector. The Company operates under four business divisions: optical disc, aircraft management, charters and brokerage. Perfect Holding SA, through its subsidiaries, is dedicated to the provision of services to the business aircraft market such as aircraft management, aircraft sales, charter sales and travel services. The Company manages medium- to large-business aircrafts, such as Bombardier Global and Challenger jets. The Company wholly owns three subsidiaries, including Perfect Aviation SA, based in Switzerland, Perfect Aviation Portugal SA, based in Portugal and Perfect Aviation UK Ltd, based in the United Kingdom.

Company Coordinates

Company Details

Avenue de Florimont 3 , LAUSANNE None : 1006

Tel: 41 21 552601641 21 5526016

https://www.perfect.aero/

Registrar Details